Pharmaceutical industry ranked one of the highest contributors to UK society

28 Jun 2019

Public perception, however, still falls far below other sectors.

The pharmaceutical industry ranks among the least successful sectors in demonstrating its value to society, a new study by Portland has revealed.

Pharmaceutical industry ranked one of the highest contributors to UK society

Portland’s inaugural Total Value Index has launched today and measures the value that organisations create for all stakeholders. It looks at nine sectors and uses a wide range of measures including profits and dividends, R&D levels, employee diversity and satisfaction to records on corporate tax and the environment, to assess and rank the total value performance of sectors. It also tests the findings against how an external informed audience thinks the different sectors are doing and why.

The pharmaceutical industry scored consistently low on perceptions for most measures. In real terms, however, Portland’s data found that they industry adds much more value than most sectors, particularly in local investment, strong dividend performance, and the presence of female CEOs. These findings reflect the opportunities for industry to communicate its real terms contribution and close the gap between opinion and reality.

Pharmaceuticals had the largest perception gap of any sector for their role as a producer, demonstrating the greater need for individual companies to explain the life-changing nature of the medicines that they create.

Negative drivers that lowered overall perceptions of the industry included public drug price debates with the NHS, Brexit stockpiling uncertainties, executive pay, and lack of transparency over clinical trials.

Dr Jane Brearley, Senior Partner and Head of Health at Portland, said: “These findings show that the pharmaceutical industry can no longer rely on old narratives of large R&D investment to raise its reputation. To cut-through to payers and the public, individual companies must centre their value story on the life-changing effects of their treatments for patients, and their ability to provide the NHS with the headroom it sorely needs”.

The Total Value Index measures the value brought to society by nine sectors – retail, TMT, banks, automotive, real estate, oil & gas, food, water and pharma.

Read More

Related news

Funding to accelerate delivery of Univercells' vaccine portfolio

Funding to accelerate delivery of Univercells' vaccine portfolio

11 Oct 2019

European financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes.

Read more 
Industrial-scale manufacture of therapeutic exosomes

Industrial-scale manufacture of therapeutic exosomes

10 Oct 2019

Coordinated purification process development service accelerates progress to clinical trials, and scale-up manufacturing.

Read more 
Janssen opens new biomanufacturing building in Ireland

Janssen opens new biomanufacturing building in Ireland

8 Oct 2019

Expansion creates 200 new full-time jobs and increases the company’s production capacity by an additional 19,100 m2.

Read more 
BASF and Biomillenia join forces in microbiome research to promote healthy skin

BASF and Biomillenia join forces in microbiome research to promote healthy skin

7 Oct 2019

Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology.

Read more 
Allergan expands Refresh eye treatment portfolio

Allergan expands Refresh eye treatment portfolio

7 Oct 2019

A trifecta of relief formulated with HydroCell technology offers new artificial tear options for patients suffering from eye dryness.

Read more 
BASF strengthens biotechnology footprint to enter natural F&F ingredients market

BASF strengthens biotechnology footprint to enter natural F&F ingredients market

3 Oct 2019

Market entrance with biotech-based natural vanillin, valencene and nootkatone.

Read more 
Unidose device approved for Tosymra sumatriptan spray

Unidose device approved for Tosymra sumatriptan spray

3 Oct 2019

Provides migraine sufferers with a convenient, patient-friendly delivery approach.

Read more 
One-stop-platform for plant-based nutraceuticals

One-stop-platform for plant-based nutraceuticals

2 Oct 2019

In 2020, nutra brands will look to ensure they have plant-based options across all product classes with many actively looking to move entire portfolios plant-based.

Read more 
BASF's new bioactive ingredient the wellness elixir for healthy skin

BASF's new bioactive ingredient the wellness elixir for healthy skin

1 Oct 2019

The active ingredient is a 100% natural extract from the chaga mushroom, obtained using an innovative eco-friendly technology: subcritical water extraction.

Read more 
Arctoris secures funding to advance novel robotic drug discovery platform

Arctoris secures funding to advance novel robotic drug discovery platform

1 Oct 2019

Platform will enable scientists and biotechnology entrepreneurs worldwide to make discoveries faster and more efficiently,

Read more